Wuxi AppTec and Pfizer have both contributed as the Yale University-founded cancer drug developer prepares for clinical testing next year.

Simcha Therapeutics, a US-based cancer therapeutics developer spun out of Yale University, has obtained $25m of series A funding from investors including pharmaceutical firm WuXi AppTec’s Corporate Venture Fund. Pharmaceutical firm Pfizer also contributed funding, as did Connecticut Innovations, the strategic venturing arm of Connecticut state, and venture capital firm Sequoia Capital China. Founded in 2018,…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.